je.st
news
Drug pricing challenges diabetes king Novo Nordisk
2013-11-05 21:05:25| Biotech - Topix.net
Drug pricing is emerging as a key challenge for Novo Nordisk, the world's biggest insulin producer, whose previously unstoppable growth has started to flag, according to the Danish firm's chief executive.
Tags: king
drug
pricing
challenges
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||